Skip to main content
SpringerLink
Log in

Early detection of liver cancer: Diagnosis and management

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer deaths worldwide, and the incidence is rising. Despite a wide array of treatment options, fewer than half of candidates for potentially curative treatments receive them. The diagnosis and management of HCC require a multidisciplinary approach involving various clinical specialties. The foundation of diagnosis is high-quality imaging, with MRI being the test of choice. Some patients also require guided biopsy when MRI is equivocal. Treatment options depend upon the tumor stage and the degree of underlying synthetic dysfunction. Potentially curative treatments include surgical resection and transplantation. Other treatments that prolong survival include percutaneous ablation and transarterial chemoembolization. A new oral agent, sorafenib, was recently shown to prolong survival in patients with advanced HCC. By increasing surveillance and treatment of HCC, outcomes for these patients may be improved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. El-Serag HB, Davila JA, Petersen NJ, et al.: The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003, 139:817–823.

    PubMed  Google Scholar 

  2. El-Serag HB: Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127(Suppl 1):S27–S34.

    Article  PubMed  Google Scholar 

  3. Stuart KE, Anand AJ, Jenkins RL: Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996, 77:2217–2222.

    Article  PubMed  CAS  Google Scholar 

  4. El-Serag HB, Siegel AB, Davila JA, et al.: Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol 2006, 44:158–166.

    Article  PubMed  Google Scholar 

  5. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005, 42:1208–1236.

    Article  PubMed  Google Scholar 

  6. Greitemeyer T, Schulz-Hardt S, Brodbeck FC, et al.: Information sampling and group decision making: the effects of an advocacy decision procedure and task experience. J Exp Psychol 2006, 12:31–42.

    Google Scholar 

  7. Fattovich G, Stroffolini T, Zagni I, et al.: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004, 127(Suppl 1):S35–S50.

    Article  PubMed  Google Scholar 

  8. Taouli B, Krinsky GA: Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation. Liver Transpl 2006, 12(Suppl 2):S1–S7.

    Article  PubMed  Google Scholar 

  9. de Ledinghen V, Laharie D, Lecesne R, et al.: Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol 2002, 14:159–165.

    Article  PubMed  Google Scholar 

  10. Krinsky GA, Lee VS, Theise ND, et al.: Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001, 219:445–454.

    PubMed  CAS  Google Scholar 

  11. Burrel M, Llovet JM, Ayuso C, et al.: MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003, 38:1034–1042.

    PubMed  Google Scholar 

  12. Rode A, Bancel B, Douek P, et al.: Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001, 25:327–336.

    Article  PubMed  CAS  Google Scholar 

  13. Schima W, Hammerstingl R, Catalano C, et al.: Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. AJR Am J Roentgenol 2006, 186:1571–1579.

    Article  PubMed  Google Scholar 

  14. Marrero JA, Hussain HK, Nghiem HV, et al.: Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 2005, 11:281–289.

    Article  PubMed  Google Scholar 

  15. Kemmer N, Neff G, Kaiser T, et al.: An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma. Liver Transpl 2006, 12:1519–1522.

    Article  PubMed  Google Scholar 

  16. Volk ML, Hernandez JC, Su GL, et al.: Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark 2007, 3:79–87.

    PubMed  CAS  Google Scholar 

  17. Caturelli E, Solmi L, Anti M, et al.: Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 2004, 53:1356–1362.

    Article  PubMed  CAS  Google Scholar 

  18. Maturen KE, Nghiem HV, Marrero JA, et al.: Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol 2006, 187:1184–1187.

    Article  PubMed  Google Scholar 

  19. Marrero JA, Fontana RJ, Barrat A, et al.: Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005, 41:707–716.

    Article  PubMed  Google Scholar 

  20. United Network for Organ Sharing: Organ distribution: allocation of livers. Policy 3.6. http://www.unos.org/PoliciesandBylaws2/policies/pdfs/policy_8.pdf. Revised December 14, 2006. Accessed October 31, 2007.

  21. Mazzaferro V, Regalia E, Doci R, et al.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693–699.

    Article  PubMed  CAS  Google Scholar 

  22. Mashoi J, Puhl S, Thyagarajan V, et al.: Liver transplantation for hepatocellular carcinoma: validation of the Milan criteria using the UNOS database. Hepatology 2006, 44(Suppl 1):407A.

    Google Scholar 

  23. Freeman RB, Edwards EB, Harper AM: Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant 2006, 6:1416–1421.

    Article  PubMed  CAS  Google Scholar 

  24. Schwartz M, Roayaie S, Uva P: Treatment of HCC in patients awaiting liver transplantation. Am J Transplant 2007, 7:1875–1881.

    Article  PubMed  CAS  Google Scholar 

  25. Fisher RA, Kulik LM, Freise CE, et al.: Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007, 7:1601–1608.

    Article  PubMed  CAS  Google Scholar 

  26. Volk ML, Marrero JA, Lok AS, et al.: Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma. Transplantation 2006, 82:1136–1139.

    Article  PubMed  Google Scholar 

  27. Yao FY, Ferrell L, Bass NM, et al.: Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002, 8:765–774.

    Article  PubMed  Google Scholar 

  28. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, et al.: Impact of UCSF criteria according to pre-and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006, 12:1761–1769.

    Article  PubMed  Google Scholar 

  29. Poon RT: Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: transplantation or resection? Ann Surg Oncol 2007, 14:541–547.

    Article  PubMed  Google Scholar 

  30. Llovet JM, Fuster J, Bruix J: Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999, 30:1434–1340.

    Article  PubMed  CAS  Google Scholar 

  31. Cheng SJ, Pratt DS, Freeman RB, Jr, et al.: Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001, 72:861–868.

    Article  PubMed  CAS  Google Scholar 

  32. Choi D, Lim HK, Rhim H, et al.: Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007, 17:684–692.

    Article  PubMed  Google Scholar 

  33. Shiina S, Teratani T, Obi S, et al.: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005, 129:122–130.

    Article  PubMed  Google Scholar 

  34. Lencioni RA, Allgaier HP, Cioni D, et al.: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003, 228:235–240.

    Article  PubMed  Google Scholar 

  35. Lin SM, Lin CJ, Lin CC, et al.: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004, 127:1714–1723.

    Article  PubMed  Google Scholar 

  36. Livraghi T, Goldberg SN, Lazzaroni S, et al.: Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000, 214:761–768.

    PubMed  CAS  Google Scholar 

  37. Sala M, Llovet JM, Vilana R, et al.: Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004, 40:1352–1360.

    Article  PubMed  Google Scholar 

  38. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003, 37:429–442.

    Article  PubMed  CAS  Google Scholar 

  39. Marelli L, Stigliano R, Triantos C, et al.: Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007, 30:6–25.

    Article  PubMed  Google Scholar 

  40. Lladó L, Virgili J, Figueras J, et al.: A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 2000, 188:50–57.

    Article  Google Scholar 

  41. Cance WG, Stewart AK, Menck HR: The National Cancer Data Base report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985–1996. Cancer 2000, 88:912–920.

    Article  PubMed  CAS  Google Scholar 

  42. Hawkins MA, Dawson LA: Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 2006, 106:1653–1663.

    Article  PubMed  Google Scholar 

  43. Ben-Josef E, Normolle D, Ensminger WD, et al.: Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005, 23:8739–8747.

    Article  PubMed  Google Scholar 

  44. Kaizu T, Karasawa K, Tanaka Y, et al.: Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients. Am J Gastroenterol 1998, 93:2167–2171.

    Article  PubMed  CAS  Google Scholar 

  45. Llovet J, Ricci S, Mazzaferro V, et al.: Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a phase III randomized placebo-controlled trial (SHARP trial) [ASCO abstract]. J Clin Oncol 2007, 25(Suppl):LBA1.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, University of Michigan Health System, 3912 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA

    Jorge A. Marrero

Authors
  1. Michael L. Volk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorge A. Marrero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jorge A. Marrero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Volk, M.L., Marrero, J.A. Early detection of liver cancer: Diagnosis and management. Curr Gastroenterol Rep 10, 60–66 (2008). https://doi.org/10.1007/s11894-008-0010-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-008-0010-2

Keywords

Search

Navigation